The bills are dead for the second year in a row, but Sun Sentinel readers still want to speak out on a plan to allow closer collaboration between Broward’s two public hospital districts.

With this new indication, pitolisant is now approved to treat excessive daytime sleepiness, cataplexy, or both, in patients aged 6 years or older with narcolepsy.

In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...

Travere Therapeutics (NASDAQ:TVTX) highlighted record demand for FILSPARI in IgA nephropathy (IgAN), provided an update on the U.S. Food and Drug Administration’s review timeline for a potential focal ...

Rosemont Pharmaceuticals announces U.S. availability of ATMEKSI® (methocarbamol) Oral Suspension, a muscle relaxant ...